Morgan Group Holding Co. (MGHL)
OTC PINK OTC PINK Primary 
Does The Kinder Morgan AI-Rally Have Further To Run?
Does The Kinder Morgan AI-Rally Have Further To Run?
Kinder Morgan: Solid Pipeline Play
Kinder Morgan, a leading US natural gas transporter, benefits from high cash flow visibility and strong balance sheets, making it a solid investment. KMI has outperformed the broader market and peers, driven by its US-focused operations, low debt, and strategic deleveraging efforts. A discounted cash flow valuation suggests a 12.29% undervaluation, with strong growth prospects fueled by rising energy demand and efficient capital deployment.
Kinder Morgan Crushed the S&P 500 in 2024. Can the High-Yielding Pipeline Giant Produce High-Octane Total Returns Again in 2025?
Shares of Kinder Morgan (KMI -0.26%) broke out in 2024. The natural gas pipeline giant had rallied more than 50% heading into the last few trading days of the year.
Morgan Stanley Series A: True Perpetual Preferred Shares, 5.9% Yield
Morgan Stanley's Series A preferred shares are unlikely to be called, making them a true perpetual security due to their advantageous coupon structure. Preferred shares offer better protection than CoCo bonds in stressed market conditions, as CoCos can incur losses even if preferred shares remain unaffected. MS.PR.A's hybrid coupon structure makes it less susceptible to interest rate fluctuations but highly sensitive to credit spreads, posing significant market risk.
Morgan Stanley Shares Up 32.4% YTD: How Will 2025 Turn Out for MS?
MS stock gains 32.4% this year. With the revival of global M&As, read on to know how 2025 will be for the stock and what investors should do.
Big Biopharma Trails Behind The Market: JP Morgan's 2025 Outlook on Eli Lilly, Merck, and More
According to JP Morgan, U.S. large-cap biopharma stocks have underperformed the broader market for two consecutive years, with mixed sentiment shaping investor outlook for 2025.
Why Morgan Stanley's Wealth Management Focus Makes It A Standout
Morgan Stanley's wealth management division achieved steady growth, contributing $6.6 billion in Q2 2024, providing stability amid volatile investment banking and trading revenues. The company returned $1.59 billion to shareholders in Q3 2024 through dividends, showcasing a strong commitment to shareholder value and confidence in long-term growth. Revenue fluctuated over the last year, peaking at $26.3 billion in Q1 2024, driven by a 15% surge in fixed-income trading activity.
Morgan Stanley: Some Of The Preferred Shares Still Yield 7%
Morgan Stanley's strong Q3 performance saw a 17% non-interest revenue increase and a 37% rise in net income attributable to common shareholders. The Series E preferred shares offer a fixed 7.125% dividend, but there's a risk of the bank calling them due to falling interest rates. A long position in these preferred shares hinges on Morgan Stanley not calling them soon. Buying close to $25 mitigates call risk.
Kinder Morgan Adds Another $1.4 Billion Project to Fuel Its More Than 4%-Yielding Dividend
Kinder Morgan (KMI 2.33%) pays its investors well. At its current share price, the natural gas pipeline giant's dividend yields 4.3% -- several times higher than the S&P 500 's 1.2% yield.
Kinder Morgan Advances $1.4B Mississippi Pipeline Project
KMI moves forward with its $1.4B Mississippi Crossing Project, aiming to add 1.5 Bcf/d gas capacity across 206 miles of pipeline in the Southeast U.S. by November 2028.
Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025
NEWARK, CA / ACCESSWIRE / December 19, 2024 / Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D.
What's Happening With Morgan Stanley Stock?
Morgan Stanley's stock (NYSE: MS) gained about 42% year-to-date. This compares to rival Goldman Sachs stock, which has seen its stock gain about 55% year-to-date.
